Tag: therapeutics

Oppenheimer lowers Allogene Therapeutics shares goal citing revised market assumptions By Investing.com

On Tuesday, Oppenheimer adjusted its value goal for Allogene Therapeutics (NASDAQ:) shares…

By admin

Nektar Therapeutics CEO sells shares price over $29,000 By Investing.com

Nektar Therapeutics (NASDAQ:) President and CEO, Howard W. Robin, has just lately…

By admin

Dyne therapeutics govt sells over $78k in inventory By Investing.com

WALTHAM, MA – Dyne Therapeutics, Inc. (NASDAQ:DYN) Chief Enterprise Officer Jonathan McNeill…

By admin

Wall Avenue eyes Alnylam’s RNAi therapeutics potential By Investing.com

Up to date Monetary Article: Alnylam Prescribed drugs' Strategic Concentrate on RNAi…

By admin